Label-free technologies are increasingly used in drug discovery for the detection and characterization of molecular interactions. The inherent advantages of label-free technology over alternative technologies like ELISA and flow cytometry are a significant factor driving its adoption. The label-free detection is a highly sensitive method used for detection of endogenous targets in cell assays, and eliminates the need for reporter labels like dyes, tags, or specialized reagents. Use of labels may confound data due to steric hindrance, and quenching. Conventional label-based technologies are usually labor intensive, cumbersome and time consuming. Label-free technologies offer the ability to analyze molecular interactions without use of labels, in small reaction volumes and are much more rapid than conventional techniques. Furthermore, increasing drug discovery programs by pharmaceutical companies and academic institutes, increase in pharmaceutical outsourcing, and increasing molecular interaction analysis in drug discovery are the important growth drivers for this market during the forecast period between 2015 and 2020.

Know More | Get Sample :- http://tinyurl.com/gpnr6yj

The report "Label-Free Detection Market by Technology (Surface Plasmon Resonance, Bio-Layer Interferometry), Products (Consumables, Microplates, Biosensor Chips), Applications (Binding Kinetics, Binding Thermodynamics, Lead Generation) - Global Forecasts to 2020" , report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global label-free detection market along with the estimates and forecasts of the revenue and share analysis.

Speak To Analyst/Experts :- http://tinyurl.com/hfob7nk

Browse 70 market data Tables and 75 Figures spread through 144 Pages and in-depth TOC on "Label-Free Detection Market by Technology (Surface Plasmon Resonance, Bio-Layer Interferometry), Products (Consumables, Microplates, Biosensor Chips), Applications (Binding Kinetics, Binding Thermodynamics, Lead Generation) - Global Forecasts to 2020"
http://www.marketsandmarkets.com/Market-Reports/label-free-detection-market-32435593.html
Early buyers will receive 10% customization on reports.

The report segments this market by technology, application, product, and geography. The technology segments included in this report are bio-layer interferometry (BLI), cellular dielectric spectroscopy, optical waveguide grating technology (OWG), surface plasmon resonance (SPR), and other technologies. Of these, the surface plasmon resonance technology segment commanded the largest share of the global label-free detection market in 2015 and is also poised to grow at the healthy CAGR between 2015 and 2020. However, bio-layer interferometry segment is will grow at the highest CAGR between 2015 and 2020. The advantage of not using any labels or reporter molecules for detection along with increasing application of biomolecular interaction analysis in drug discovery are driving the growth of this technology segment.

The application segments included in this report are binding kinetics, binding thermodynamics, endogenous receptor detection, hit confirmation, lead generation, and other application segments. The binding kinetics application segment commanded the largest share of the global label-free detection market in 2015, while the hit confirmation segment is poised to grow at the highest CAGR between 2015 and 2020. The binding kinetic studies measure drug residence time, which are important for predicting clinical outcome of drug candidates. As such, the development in drug discovery will boost the binding kinetics studies and drive the label-free detection market.

The product segments in this report are instruments and consumables. Of these, the instrument segment commanded the largest share of the global label-free detection market in 2015 and is also poised to grow at the healthy CAGR between 2015 and 2020. Enhanced instrumentation makes it possible for pharmaceutical and biotechnology companies to streamline and simplify laboratory workflows, improve productivity and leads to reduction in the costs. Increasing adoption of label-free detection technologies in drug discovery will boost the growth of instruments in the forecast period.

Based on geography, the global label-free detection market is segmented into geographic segments of Asia, Europe, North America, and the Rest of the World (RoW).

The major players in the label-free detection market are Ametek, Inc. (U.S.), Attana AB (Sweden), Bio-Rad Laboratories, Inc. (U.S.), BiOptix (USA), Corning, Inc. (U.S.), Danaher Corporation (U.S.), General Electric Corporation (U.S.), Pall Corporation (U.S.), PerkinElmer (U.S.), and Roche (Switzerland).